<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Orbai AM</submitter><funding>Jerome L. Greene Foundation</funding><funding>Pfizer</funding><funding>National Institute for Health Research (NIHR)</funding><funding>NIAMS NIH HHS</funding><pagination>1772-1779</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7153974</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>72(12)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Sex differences may modify symptoms, disease expression, and treatment effects. The objective of this study was to evaluate the link between life impact and sex in psoriatic arthritis (PsA).&lt;h4>Methods&lt;/h4>Remission and Flare in Psoriatic Arthritis (ReFlaP; ClinicalTrials.gov identifier: NCT03119805) was a study in 14 countries of consecutive adult patients with definite PsA. Participants underwent comprehensive PsA assessment using the following measures: Disease Activity in Psoriatic Arthritis (DAPSA), Minimal Disease Activity (MDA), and Psoriatic Arthritis Impact of Disease (PsAID). Disease activity was compared by sex using t-tests or Wilcoxon tests. The association of PsAID with sex was analyzed using hierarchical generalized linear models.&lt;h4>Results&lt;/h4>Of 458 part</pubmed_abstract><journal>Arthritis care &amp; research</journal><pubmed_title>Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries.</pubmed_title><pmcid>PMC7153974</pmcid><funding_grant_id>Jerome L Greene Foundation Scholar</funding_grant_id><funding_grant_id>CL-2011-02-001</funding_grant_id><funding_grant_id>CS-2016-16-016</funding_grant_id><funding_grant_id>P30 AR070254</funding_grant_id><pubmed_authors>Orbai AM</pubmed_authors><pubmed_authors>Kalyoncu U</pubmed_authors><pubmed_authors>Kiltz U</pubmed_authors><pubmed_authors>Dernis E</pubmed_authors><pubmed_authors>Scrivo R</pubmed_authors><pubmed_authors>Aydin S</pubmed_authors><pubmed_authors>Canete JD</pubmed_authors><pubmed_authors>Richette P</pubmed_authors><pubmed_authors>Perin J</pubmed_authors><pubmed_authors>Gorlier C</pubmed_authors><pubmed_authors>de Wit M</pubmed_authors><pubmed_authors>Coates LC</pubmed_authors><pubmed_authors>Palominos PE</pubmed_authors><pubmed_authors>Ruyssen-Witrand A</pubmed_authors><pubmed_authors>Eder L</pubmed_authors><pubmed_authors>Leung YY</pubmed_authors><pubmed_authors>Talli S</pubmed_authors><pubmed_authors>Smolen JS</pubmed_authors><pubmed_authors>Gaydukova I</pubmed_authors><pubmed_authors>Gossec L</pubmed_authors><pubmed_authors>Soubrier M</pubmed_authors><pubmed_authors>Lubrano E</pubmed_authors><pubmed_authors>Husni ME</pubmed_authors><pubmed_authors>Balanescu A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries.</name><description>&lt;h4>Objective&lt;/h4>Sex differences may modify symptoms, disease expression, and treatment effects. The objective of this study was to evaluate the link between life impact and sex in psoriatic arthritis (PsA).&lt;h4>Methods&lt;/h4>Remission and Flare in Psoriatic Arthritis (ReFlaP; ClinicalTrials.gov identifier: NCT03119805) was a study in 14 countries of consecutive adult patients with definite PsA. Participants underwent comprehensive PsA assessment using the following measures: Disease Activity in Psoriatic Arthritis (DAPSA), Minimal Disease Activity (MDA), and Psoriatic Arthritis Impact of Disease (PsAID). Disease activity was compared by sex using t-tests or Wilcoxon tests. The association of PsAID with sex was analyzed using hierarchical generalized linear models.&lt;h4>Results&lt;/h4>Of 458 part</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2026-05-02T11:45:39.204Z</modification><creation>2022-02-11T13:21:45.134Z</creation></dates><accession>S-EPMC7153974</accession><cross_references><pubmed>31609525</pubmed><doi>10.1002/acr.24090</doi></cross_references></HashMap>